These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20631190)

  • 1. Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia.
    Chung SK; Vanbellinghen JF; Mullins JG; Robinson A; Hantke J; Hammond CL; Gilbert DF; Freilinger M; Ryan M; Kruer MC; Masri A; Gurses C; Ferrie C; Harvey K; Shiang R; Christodoulou J; Andermann F; Andermann E; Thomas RH; Harvey RJ; Lynch JW; Rees MI
    J Neurosci; 2010 Jul; 30(28):9612-20. PubMed ID: 20631190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel missense mutations in the glycine receptor β subunit gene (GLRB) in startle disease.
    James VM; Bode A; Chung SK; Gill JL; Nielsen M; Cowan FM; Vujic M; Thomas RH; Rees MI; Harvey K; Keramidas A; Topf M; Ginjaar I; Lynch JW; Harvey RJ
    Neurobiol Dis; 2013 Apr; 52():137-49. PubMed ID: 23238346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLRB is the third major gene of effect in hyperekplexia.
    Chung SK; Bode A; Cushion TD; Thomas RH; Hunt C; Wood SE; Pickrell WO; Drew CJ; Yamashita S; Shiang R; Leiz S; Longardt AC; Raile V; Weschke B; Puri RD; Verma IC; Harvey RJ; Ratnasinghe DD; Parker M; Rittey C; Masri A; Lingappa L; Howell OW; Vanbellinghen JF; Mullins JG; Lynch JW; Rees MI
    Hum Mol Genet; 2013 Mar; 22(5):927-40. PubMed ID: 23184146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia.
    Rees MI; Lewis TM; Vafa B; Ferrie C; Corry P; Muntoni F; Jungbluth H; Stephenson JB; Kerr M; Snell RG; Schofield PR; Owen MJ
    Hum Genet; 2001 Sep; 109(3):267-70. PubMed ID: 11702206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutation of GLRA1 in Omani families with hyperekplexia and mild mental retardation.
    Al-Futaisi AM; Al-Kindi MN; Al-Mawali AM; Koul RL; Al-Adawi S; Al-Yahyaee SA
    Pediatr Neurol; 2012 Feb; 46(2):89-93. PubMed ID: 22264702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of hyperekplexia: more than startle!
    Harvey RJ; Topf M; Harvey K; Rees MI
    Trends Genet; 2008 Sep; 24(9):439-47. PubMed ID: 18707791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis.
    Elmslie FV; Hutchings SM; Spencer V; Curtis A; Covanis T; Gardiner RM; Rees M
    J Med Genet; 1996 May; 33(5):435-6. PubMed ID: 8733061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.
    Thomas RH; Chung SK; Wood SE; Cushion TD; Drew CJ; Hammond CL; Vanbellinghen JF; Mullins JG; Rees MI
    Brain; 2013 Oct; 136(Pt 10):3085-95. PubMed ID: 24030948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
    Carta E; Chung SK; James VM; Robinson A; Gill JL; Remy N; Vanbellinghen JF; Drew CJ; Cagdas S; Cameron D; Cowan FM; Del Toro M; Graham GE; Manzur AY; Masri A; Rivera S; Scalais E; Shiang R; Sinclair K; Stuart CA; Tijssen MA; Wise G; Zuberi SM; Harvey K; Pearce BR; Topf M; Thomas RH; Supplisson S; Rees MI; Harvey RJ
    J Biol Chem; 2012 Aug; 287(34):28975-85. PubMed ID: 22700964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Missense Mutation A384P Associated with Human Hyperekplexia Reveals a Desensitization Site of Glycine Receptors.
    Wang CH; Hernandez CC; Wu J; Zhou N; Hsu HY; Shen ML; Wang YC; Macdonald RL; Wu DC
    J Neurosci; 2018 Mar; 38(11):2818-2831. PubMed ID: 29440552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperekplexia: a treatable neurogenetic disease.
    Zhou L; Chillag KL; Nigro MA
    Brain Dev; 2002 Oct; 24(7):669-74. PubMed ID: 12427512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and genetic analysis of two siblings with startle disease in an Italian family: a case report.
    Sprovieri T; Ungaro C; Sivo S; Quintiliani M; Contaldo I; Veredice C; Citrigno L; Muglia M; Cavalcanti F; Cavallaro S; Mercuri E; Battaglia D
    BMC Med Genet; 2019 Mar; 20(1):40. PubMed ID: 30866851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
    Rees MI; Harvey K; Pearce BR; Chung SK; Duguid IC; Thomas P; Beatty S; Graham GE; Armstrong L; Shiang R; Abbott KJ; Zuberi SM; Stephenson JB; Owen MJ; Tijssen MA; van den Maagdenberg AM; Smart TG; Supplisson S; Harvey RJ
    Nat Genet; 2006 Jul; 38(7):801-6. PubMed ID: 16751771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel GLRA1 mutation associated with an atypical hyperekplexia phenotype.
    Gregory ML; Guzauskas GF; Edgar TS; Clarkson KB; Srivastava AK; Holden KR
    J Child Neurol; 2008 Dec; 23(12):1433-8. PubMed ID: 19073849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutations.
    Vergouwe MN; Tijssen MA; Peters AC; Wielaard R; Frants RR
    Ann Neurol; 1999 Oct; 46(4):634-8. PubMed ID: 10514101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperekplexia-like syndromes without mutations in the GLRA1 gene.
    Vergouwe MN; Tijssen MA; Shiang R; van Dijk JG; al Shahwan S; Ophoff RA; Frants RR
    Clin Neurol Neurosurg; 1997 Aug; 99(3):172-8. PubMed ID: 9350397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.
    Giménez C; Pérez-Siles G; Martínez-Villarreal J; Arribas-González E; Jiménez E; Núñez E; de Juan-Sanz J; Fernández-Sánchez E; García-Tardón N; Ibáñez I; Romanelli V; Nevado J; James VM; Topf M; Chung SK; Thomas RH; Desviat LR; Aragón C; Zafra F; Rees MI; Lapunzina P; Harvey RJ; López-Corcuera B
    J Biol Chem; 2012 Aug; 287(34):28986-9002. PubMed ID: 22753417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperekplexia (startle disease): a novel mutation (S270T) in the M2 domain of the GLRA1 gene and a molecular review of the disorder.
    Lapunzina P; Sánchez JM; Cabrera M; Moreno A; Delicado A; de Torres ML; Mori AM; Quero J; Lopez Pajares I
    Mol Diagn; 2003; 7(2):125-8. PubMed ID: 14580232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperekplexia: abnormal startle response due to glycine receptor mutations.
    Andrew M; Owen MJ
    Br J Psychiatry; 1997 Feb; 170():106-8. PubMed ID: 9093496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.
    Eulenburg V; Becker K; Gomeza J; Schmitt B; Becker CM; Betz H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):400-5. PubMed ID: 16884688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.